8-K - Zai Lab Ltd (0001704292) (Filer)
Published . Updated .
Key takeaways
- 8-K - Zai Lab filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
- Exposed: ZLAB
- Market reaction: price tracking starts with the next trading session.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Zai Lab filed an 8-K with the SEC on Nov 5 (a notice of a material company event).
Directly affected
- ZLAB Zai Lab+3.6% 10d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Zai Lab belongs to, so it often moves with news about it.
- LLY Eli Lilly and+19.9% 30d
Eli Lilly and is a peer of Zai Lab in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+1.9% 30d
Johnson & Johnson is a peer of Zai Lab in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+11.3% 30d
AbbVie is a peer of Zai Lab in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+5.9% 19d
Merck is a peer of Zai Lab in pharmaceutical preparations; rivals often move on the same news.
- NVS Novartis AG-0.1% 14d
Novartis AG is a peer of Zai Lab in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ZLAB | -1.97% | -4.95% | base | after close | after close | after close | after close |
| XLV | -2.96% | -2.66% | base | after close | after close | after close | after close |
| LLY | -3.15% | -0.45% | base | after close | after close | after close | after close |
| JNJ | -0.43% | -2.09% | base | after close | after close | after close | after close |
| ABBV | -1.41% | -2.06% | base | after close | after close | after close | after close |
| MRK | -2.69% | -1.28% | base | after close | after close | after close | after close |
| NVS | -2.40% | -2.15% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-05 AccNo: 0001628280-26-070517 Size: 397 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 5 Nov 2026: Zai Lab (ZLAB) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | three days earlier | -2.06% | final price |
| ABBV | five days earlier | -1.41% | final price |
| JNJ | three days earlier | -2.09% | final price |
| JNJ | five days earlier | -0.43% | final price |
| LLY | three days earlier | -0.45% | final price |
| LLY | five days earlier | -3.15% | final price |
| MRK | three days earlier | -1.28% | final price |
| MRK | five days earlier | -2.69% | final price |
| NVS | three days earlier | -2.15% | final price |
| NVS | five days earlier | -2.40% | final price |
| XLV | three days earlier | -2.66% | final price |
| XLV | five days earlier | -2.96% | final price |
| Zai Lab (ZLAB) | three days earlier | -4.95% | final price |
| Zai Lab (ZLAB) | five days earlier | -1.97% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 36 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 41 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 58 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 52 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 42 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 78 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Kevin Hern sold Novartis Ag (NVS), worth $15,001 - $50,000 on 27 Aug 2026. That is 70 days before publication. Filed 25 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who is named in “8-K - Zai Lab Ltd (0001704292) (Filer)”
Companies mentioned with this story
- ZLAB Zai Lab
For “8-K - Zai Lab Ltd (0001704292) (Filer),” Zai Lab (ZLAB) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> ZLAB
How “8-K - Zai Lab Ltd (0001704292) (Filer)” reaches Zai Lab (ZLAB)
“8-K - Zai Lab Ltd (0001704292) (Filer)” (5 Nov 2026) reaches Zai Lab (ZLAB) through this story.
The link for Zai Lab (ZLAB) is this: SEC 8-K filing -> direct issuer disclosure -> ZLAB
Price levels for Zai Lab (ZLAB)
ZLAB traded between 21.51 and 24.50 across 10 sessions. The latest close on file is 22.83.
A simple score for Zai Lab (ZLAB)
14 out of 100
“8-K - Zai Lab Ltd (0001704292) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.